
Genetron Holdings Limited GTH
Geschäftsbericht 2022
hinzugefügt 21.12.2024
Genetron Holdings Limited ROCE 2011-2026 | GTH
ROCE Jährlich Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -15.41 | -85.06 | -90.77 | -38.95 | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -15.41 | -90.77 | -57.55 |
ROCE anderer Aktien in der Diagnostik & Forschung
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
25.0 | $ 120.47 | 1.2 % | $ 36.6 B | ||
|
Anixa Biosciences
ANIX
|
-77.18 | $ 2.9 | 2.47 % | $ 94.1 K | ||
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 22.13 | -5.98 % | $ 243 M | ||
|
Celcuity
CELC
|
-97.97 | $ 108.86 | 1.36 % | $ 4.29 B | ||
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
1.9 | $ 27.97 | 1.43 % | $ 777 M | ||
|
Fulgent Genetics
FLGT
|
-6.52 | $ 14.17 | 2.72 % | $ 428 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | ||
|
Charles River Laboratories International
CRL
|
0.8 | $ 179.12 | 1.95 % | $ 8.88 B | ||
|
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | ||
|
IDEXX Laboratories
IDXX
|
61.76 | $ 638.42 | 0.62 % | $ 51.3 B | ||
|
Illumina
ILMN
|
-35.1 | $ 131.73 | 1.67 % | $ 20.9 B | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 282.44 | -0.19 % | $ 23.5 B | ||
|
Lantheus Holdings
LNTH
|
28.52 | $ 79.34 | 0.63 % | $ 5.35 B | ||
|
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
-41.6 | $ 15.04 | -2.97 % | $ 1.95 B | ||
|
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | ||
|
Mettler-Toledo International
MTD
|
35.8 | $ 1 319.33 | 0.2 % | $ 27.2 B | ||
|
Myriad Genetics
MYGN
|
-105.22 | $ 5.43 | 2.65 % | $ 503 M | ||
|
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | ||
|
NeoGenomics
NEO
|
-9.11 | $ 9.65 | 1.1 % | $ 1.24 B | ||
|
BioNano Genomics
BNGO
|
-293.94 | $ 1.12 | - | $ 1.42 M | ||
|
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 209.29 | 0.44 % | $ 23.2 B | ||
|
Danaher Corporation
DHR
|
8.93 | $ 204.98 | 0.48 % | $ 146 B | ||
|
National Research Corporation
NRC
|
81.8 | $ 13.39 | - | $ 329 M | ||
|
Organovo Holdings
ONVO
|
-120.24 | - | -2.3 % | $ 19.4 M | ||
|
Exact Sciences Corporation
EXAS
|
-8.59 | $ 103.46 | 0.09 % | $ 19.5 B | ||
|
Bioventus
BVS
|
-47.08 | $ 8.57 | -1.95 % | $ 537 M | ||
|
OPKO Health
OPK
|
-7.58 | $ 1.21 | 1.68 % | $ 840 M | ||
|
DarioHealth Corp.
DRIO
|
-66.97 | $ 10.5 | 1.94 % | $ 298 M | ||
|
DexCom
DXCM
|
33.2 | $ 71.55 | -2.09 % | $ 27.9 B | ||
|
PerkinElmer
PKI
|
4.92 | - | -0.91 % | $ 14.7 B | ||
|
Pacific Biosciences of California
PACB
|
-10354.48 | $ 1.62 | 6.25 % | $ 486 M | ||
|
Psychemedics Corporation
PMD
|
-43.78 | - | -1.84 % | $ 15.3 M | ||
|
QIAGEN N.V.
QGEN
|
1.9 | - | - | $ 10.6 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 111.03 | 2.14 % | $ 9.16 B | ||
|
Quotient Limited
QTNT
|
232.42 | - | -11.32 % | $ 1.1 M | ||
|
Precipio
PRPO
|
-52.81 | $ 25.4 | 1.7 % | $ 33 M | ||
|
Renalytix AI plc
RNLX
|
376.98 | - | 5.66 % | $ 22.7 M | ||
|
CareDx, Inc
CDNA
|
-10.16 | $ 19.2 | 2.13 % | $ 1.02 B | ||
|
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M |